264049503	264049503	CD	B-NP	O
|	|	NN	I-NP	O
BUMC	BUMC	NN	I-NP	O
|	|	NN	I-NP	O
63008698	63008698	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9104892	9104892	CD	B-NP	O
|	|	CC	I-NP	O
4/29/2004	4/29/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/29/2004	4/29/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/1/2004	3/1/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BRIGNOLO	BRIGNOLO	NNP	B-NP	O
,	,	,	O	O
CHUCK	CHUCK	NNP	B-NP	O
321-31-20-4	321-31-20-4	CD	I-NP	O
Platnof	Platnof	NNP	I-NP	O
Ave.	Ave.	NNP	I-NP	O
,	,	,	O	O
Chibroke	Chibroke	NNP	B-NP	O
Ri	Ri	NNP	I-NP	O
Ce	Ce	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/26/05	6/26/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROURK	ROURK	NNP	B-NP	O
,	,	,	O	O
BRYON	BRYON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/3	5/3	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	I-protein
SODIUM	SODIUM	NN	I-NP	I-protein
75	75	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NITROGLYCERIN	NITROGLYCERIN	NNP	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
0.4	0.4	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
Q5MIN	Q5MIN	NN	I-NP	I-protein
X	X	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/3	5/3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
LASIX	LASIX	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
GLUCOPHAGE	GLUCOPHAGE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
BENICAR	BENICAR	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Knickrehm	Knickrehm	NNP	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
at	at	IN	B-PP	O
Bipa	Bipa	NNP	B-NP	O
Healthcare	Healthcare	NNP	I-NP	O
Center	Center	NNP	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p	p	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Gavilanes	Gavilanes	NNP	I-NP	O
at	at	IN	B-PP	O
Nysi	Nysi	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appt	appt	NN	I-NP	O
in	in	IN	B-PP	O
2-3wks	2-3wk	NNS	B-NP	O
.	.	.	O	O

086-463-7490	086-463-7490	CD	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
program	program	NN	I-NP	O
on	on	IN	B-PP	O
Thurs	Thurs	NNP	B-NP	O
November	November	NNP	I-NP	O
with	with	IN	B-PP	O
Devin	Devin	NNP	B-NP	O
Apana	Apana	NNP	I-NP	O
at	at	IN	B-PP	O
Sadeland	Sadeland	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
086-463-7490	086-463-7490	CD	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p	p	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NN	B-NP	O
TYPE	TYPE	NN	I-NP	O
IV	IV	CD	I-NP	O
HYPERCHOLESTEROLEMI	HYPERCHOLESTEROLEMI	NN	I-NP	O
SMOKER	SMOKER	NN	I-NP	O
FHX	FHX	NN	I-NP	O
HTN	HTN	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
CAD	CAD	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catherization	catherization	NN	I-NP	O
w/stent	w/stent	NN	I-NP	O
for	for	IN	B-PP	O
SVG	SVG	NN	B-NP	B-protein
to	to	TO	B-PP	O
RPDA	RPDA	NN	B-NP	B-protein
and	and	CC	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
48	48	CD	B-NP	O
M	M	NN	I-NP	O
admitted	admit	VBN	B-VP	O
via	via	IN	B-PP	O
ED	ED	VBN	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
dyspnoea	dyspnoea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
oedema	oedema	NN	I-NP	O
.	.	.	O	O

HCC	HCC	NN	B-NP	O
:	:	:	O	O
48	48	CD	B-NP	O
N	N	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
Type	Type	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
DM	DM	NN	I-NP	I-protein
,	,	,	O	O
hypercholesterolaemia	hypercholesterolaemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
EtOH	EtOH	NN	B-NP	O
use	use	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
SOBOE	SOBOE	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
oedema	oedema	NN	I-NP	O
.	.	.	O	O

Describes	Describe	VBZ	B-VP	O
clear	clear	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
orthopnoea	orthopnoea	NN	B-NP	O
and	and	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
chest	chest	VBP	B-VP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
light-headedness	light-headedness	NN	B-NP	O
,	,	,	O	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
malaise	malaise	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
systemic	systemic	JJ	I-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
Diabetes	Diabetes	NN	B-NP	O
,	,	,	O	O
alcohol	alcohol	NN	B-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	B-DNA
1997	1997	CD	I-NP	I-DNA
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
.	.	.	O	O

DH	DH	NN	B-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
,	,	,	O	O
benicar	benicar	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
.	.	.	O	O

FH	FH	NN	B-NP	O
:	:	:	O	O
Nil	Nil	NN	B-NP	B-protein
of	of	IN	B-PP	O
note	note	NN	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
Smokes	Smoke	NNS	B-NP	O
1ppd	1ppd	NN	I-NP	O
,	,	,	O	O
EtoH	EtoH	NN	B-NP	O
6	6	CD	I-NP	O
beers/day	beers/day	NN	I-NP	O
O/E	O/E	NN	I-NP	O
:	:	:	O	O
Mildly	Mildly	RB	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
T	T	NN	B-NP	B-cell_line
97.9	97.9	CD	I-NP	I-cell_line
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
147/105	147/105	CD	I-NP	I-DNA
,	,	,	O	O
HR	HR	NN	B-NP	B-cell_line
108	108	CD	I-NP	I-cell_line
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
24	24	CD	I-NP	I-protein
,	,	,	O	O
Sats	Sat	VBZ	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Facial	Facial	JJ	B-NP	O
plethora	plethora	NN	I-NP	O
&	&	CC	I-NP	O
dusky	dusky	JJ	I-NP	O
hue	hue	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
jaundice	jaundice	NN	I-NP	O
,	,	,	O	O
pallor	pallor	NN	B-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
lymphadenopathy	lymphadenopathy	NN	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
earlobes	earlobe	NNS	I-NP	O
.	.	.	O	O

HS	HS	NN	B-NP	B-DNA
I	I	CD	I-NP	I-DNA
+	+	SYM	I-NP	O
II	II	CD	I-NP	O
+	+	SYM	I-NP	O
S3	S3	NN	I-NP	B-protein
with	with	IN	B-PP	O
gallop	gallop	NN	B-NP	O
.	.	.	O	O

Occasional	Occasional	JJ	B-NP	O
bibasal	bibasal	JJ	I-NP	O
coarse	coarse	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
distended	distend	VBN	B-VP	O
with	with	IN	B-PP	O
shifting	shift	VBG	B-VP	O
dullness	dullness	NN	B-NP	O
&	&	CC	I-NP	O
mild	mild	JJ	I-NP	O
RUQ	RUQ	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
oedema	oedema	NN	B-NP	O
to	to	TO	B-PP	O
knees	knee	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Rash	Rash	NN	B-NP	O
behind	behind	IN	B-PP	O
calves	calf	NNS	B-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
BNP	BNP	NN	B-NP	O
1900	1900	CD	I-NP	O
,	,	,	O	O
TnI	TnI	NN	B-NP	B-protein
-	-	HYPH	O	O
ve	ve	NN	B-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	O
52	52	CD	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
New	New	NNP	B-NP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
oedema	oedema	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
:	:	:	O	O
Unchanged	Unchanged	JJ	B-ADJP	O
.	.	.	O	O

TWI	TWI	NN	B-NP	O
V4-V6	V4-V6	NN	I-NP	O
.	.	.	O	O

Nil	Nil	NNP	B-NP	O
acutely	acutely	RB	B-ADJP	O
ischaemic	ischaemic	JJ	I-ADJP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

New	New	JJ	B-NP	O
onset	onset	NN	I-NP	O
R	R	NN	I-NP	O
>	>	SYM	B-NP	O
L	L	NN	I-NP	O
dilated	dilate	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
ischemic	ischemic	JJ	B-NP	O
dz	dz	NN	I-NP	O
and	and	CC	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
grafts	graft	NNS	B-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
cabg	cabg	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
cycled	cycle	VBN	I-VP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
w/a	w/a	SYM	I-NP	O
troponin	troponin	NN	I-NP	O
bump	bump	NN	I-NP	O
on	on	IN	B-PP	O
second	second	JJ	B-NP	O
set	set	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
by	by	IN	B-PP	O
3rd	3rd	NN	B-NP	O
set	set	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
r/o	r/o	VBP	B-VP	O
'd	'd	MD	O	O
for	for	IN	B-PP	O
hemochromatosis	hemochromatosis	NN	B-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
.	.	.	O	O

W/u	W/u	NN	B-NP	O
of	of	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
new-onset	new-onset	JJ	I-NP	O
chf	chf	NN	I-NP	O
included	include	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
w/EF	w/EF	NN	I-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
then	then	RB	B-ADVP	O
recieved	recieve	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catherization	catherization	NN	I-NP	O
on	on	IN	B-PP	O
6/14	6/14	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
.	.	.	O	O

elevated	elevate	VBN	B-NP	O
L	L	NN	I-NP	O
heart	heart	NN	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
at	at	IN	B-PP	O
29mmHg	29mmHg	NN	B-NP	O
and	and	CC	I-NP	O
PA	PA	NN	I-NP	O
sat	sit	VBD	B-VP	O
fo	fo	RB	B-NP	O
49	49	CD	I-NP	O
%	%	NN	I-NP	O
c/w	c/w	NN	I-NP	O
Lheart	Lheart	NN	I-NP	O
failure	failure	NN	I-NP	O
;	;	:	O	O
2	2	LS	B-LST	O
.	.	.	O	O

LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
70-80	70-80	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
distal	distal	JJ	B-NP	B-DNA
anastomotic	anastomotic	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
;	;	:	O	O
3	3	LS	B-LST	O
.	.	.	O	O

diminished	diminish	VBN	B-NP	O
baseline	baseline	NN	I-NP	O
flow	flow	NN	I-NP	O
of	of	IN	B-PP	O
SVG	SVG	NN	B-NP	B-protein
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	O
s/p	s/p	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
ST	ST	NN	I-NP	O
elevation	elevation	NN	I-NP	O
during	during	IN	B-PP	O
cath	cath	NN	B-NP	O
,	,	,	O	O
relieved	relieved	JJ	B-NP	O
w/ng	w/ng	NN	I-NP	O
.	.	.	O	O

O/N	O/N	NN	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
episodes	episode	VBZ	B-VP	O
NSVT	NSVT	NN	B-NP	B-protein
.	.	.	O	O

Re-cathed	Re-cathed	JJ	B-ADJP	O
on	on	IN	B-PP	O
5/29	5/29	CD	B-NP	O
as	as	IN	B-SBAR	O
planned	plan	VBN	B-VP	O
after	after	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
for	for	IN	B-PP	O
stenting	stente	VBG	B-NP	O
of	of	IN	B-PP	O
LIMA	LIMA	NN	B-NP	B-protein
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	O
one	one	CD	I-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
2nd	2nd	JJ	B-NP	O
cath	cath	NN	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
w/steady	w/steady	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
d/c	d/c	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
sob	sob	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	I-NP	O
pnd	pnd	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

Jvp	Jvp	NN	B-NP	B-protein
was	be	VBD	B-VP	O
wnl	wnl	JJ	B-NP	O
,	,	,	I-NP	O
hepatic	hepatic	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
distended	distend	VBN	B-ADJP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
swelling	swell	VBG	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
d/c	d/c	NN	I-NP	O
wt	wt	NN	I-NP	O
was	be	VBD	B-VP	O
194.0	194.0	CD	B-NP	O
lb	lb	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
f/u	f/u	VB	I-VP	O
w/CHF	w/CHF	NN	B-NP	O
program	program	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
,	,	,	O	O
cardiologist	cardiologist	NN	B-NP	O
in	in	IN	B-PP	O
2-3wks	2-3wk	NNS	B-NP	O
and	and	CC	O	O
EP	EP	NN	B-NP	O
service	service	NN	I-NP	O
in	in	IN	B-PP	O
6wks	6wk	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
f/u	f/u	NN	B-NP	B-protein
echo	echo	NN	I-NP	I-protein
b/4	b/4	CD	I-NP	I-protein
his	his	PRP$	B-NP	O
EF	EF	NN	I-NP	O
appt	appt	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NNP	B-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
d/c	d/c	NN	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
diabetic	diabetic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
consult	consult	NN	I-NP	O
to	to	TO	B-VP	O
review	review	VB	I-VP	O
2g	2g	NN	B-NP	O
sodium/2L	sodium/2L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
diet	diet	NN	I-NP	O
PSYCH	PSYCH	NN	I-NP	O
:	:	:	O	O
Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addiction	addiction	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
no	no	DT	B-NP	O
signs/symptoms	signs/symptom	NNS	I-NP	O
of	of	IN	B-PP	O
etoh	etoh	NN	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Declined	Declined	JJ	B-NP	O
antidepressants	antidepressant	NNS	I-NP	O
,	,	,	O	O
nicotine	nicotine	NN	B-NP	O
patch	patch	NN	I-NP	O
but	but	CC	O	O
agreed	agree	VBD	B-VP	O
to	to	TO	B-PP	O
counseling	counseling	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
encouraged	encourage	VBD	B-VP	O
to	to	TO	I-VP	O
stop	stop	VB	I-VP	O
drinking	drinking	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
quit	quit	VB	I-VP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
:	:	:	O	O
stable	stable	JJ	B-NP	O
DISPO	DISPO	NN	I-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
w/close	w/close	NN	I-NP	O
CHF	CHF	NN	I-NP	O
program	program	NN	I-NP	O
f/u	f/u	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
call	call	VB	B-VP	O
md	md	NN	B-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
temp	temp	NN	B-NP	O
over	over	IN	B-PP	O
100.4	100.4	CD	B-NP	O
or	or	CC	O	O
anything	anything	NN	B-NP	O
concerning	concern	VBG	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Echo	Echo	NN	B-NP	O
in	in	IN	B-PP	O
4-6	4-6	CD	B-NP	O
wks	wk	NNS	I-NP	O
before	before	IN	B-PP	O
appt	appt	NN	B-NP	O
w/Dr	w/Dr	NN	I-NP	O
Stith	Stith	NN	I-NP	O
on	on	IN	B-PP	O
2/16/05	2/16/05	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
RAVE	RAVE	NN	B-NP	O
,	,	,	O	O
VINCE	VINCE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZA549	ZA549	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/14/04	5/14/04	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
34	34	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

